| Vol. 15.08 – 9 March, 2023 |
| |
|
|
| The authors determined the changes in various immune cells, especially macrophages and monocytes, involved in the effects of MSC treatment on pulmonary fibrosis. [Respiratory Research] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The role of serum amyloid A1 in chemokine expression and leukocyte chemotaxis was examined in cultured human amnion tissue explants as well as primary human amnion fibroblasts. [Inflammation Research] |
|
|
|
| Scientists defined the effects and underlying mechanisms of human amniotic membrane-derived MSCs regulating the gut microbiota and intestinal immunity in acute graft-versus-host disease (aGVHD). [Stem Cell Reviews and Reports] |
|
|
|
| Investigators showed that the physiological medium, Plasmaxä, with nutrient and metabolite concentrations recapitulating human plasma improved human trophoblast stem cell proliferation and differentiation compared to standard medium. [American Journal of Physiology-Cell Physiology] |
|
|
|
| Scientists determined whether the systemic administration of umbilical cord-derived MSCs in the early postnatal period could attenuate neuroinflammation and thereby prevent the emergence of neurodevelopmental disorders. [Scientific Reports] |
|
|
|
| Researchers compared monocytes from human bone marrow, peripheral blood, and umbilical cord blood and their osteoclastogenic potential by culturing them with RANKL and M-CSF for 14 days. [Scientific Reports] |
|
|
|
| Scanning electron microscope and MTT assays showed significant cellular proliferation and viability on the proposed scaffolds, and these analyses illustrated that higher cell survival and adhesion could be achieved when scaffolds possessed a larger amount of amniotic membrane. [Artificial Organs] |
|
|
|
|
| The authors review the general characteristics of the epithelial stem cells isolated from the human amniotic membrane as well as their ability to differentiate into hepatic cells. [Placenta] |
|
|
|
|
| The total cost of cancer to the global economy will reach 25.2 trillion international dollars between 2020 and 2050, according to an analysis of 29 cancers across 204 countries. [Nature] |
|
|
|
|
| April 24 – 26, 2023 Hinxton, England, United Kingdom |
|
|
|
|
|
| Karolinska Institute – Solna, Sweden |
|
|
|
| The University of Melbourne – Melbourne, Australia |
|
|
|
| Beth Israel Deaconess Medical Center – Boston, Massachusetts, United States |
|
|
|
| The Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus – Frankfurt, Germany |
|
|
|
| Medical College of Wisconsin – Milwaukee, Wisconsin, United States |
|
|
|
|